Advertisement
Advertisement
U.S. markets open in 4 hours 43 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NewAge, Inc. (NBEV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4200-0.0500 (-3.40%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.4700
Open1.4900
Bid0.0000 x 800
Ask0.0000 x 3200
Day's Range1.4100 - 1.4700
52 Week Range1.3500 - 4.5500
Volume794,033
Avg. Volume1,006,165
Market Cap194.239M
Beta (5Y Monthly)1.23
PE Ratio (TTM)N/A
EPS (TTM)-0.2600
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NBEV

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NewAge, Inc.
    Analyst Report: Cronos Group Inc.Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
    Rating
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more
Advertisement
Advertisement